

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 5.90403193 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.89156815 |
| 3 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.62480749 |
| 4 | locomotory exploration behavior (GO:0035641) | 5.61513549 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 5.19559507 |
| 6 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.13826523 |
| 7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.12693380 |
| 8 | vocalization behavior (GO:0071625) | 5.00092635 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.86351639 |
| 10 | neuronal action potential propagation (GO:0019227) | 4.79328659 |
| 11 | glutamate secretion (GO:0014047) | 4.73942115 |
| 12 | regulation of synaptic vesicle transport (GO:1902803) | 4.47478112 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.46454268 |
| 14 | neuron cell-cell adhesion (GO:0007158) | 4.37695405 |
| 15 | protein localization to synapse (GO:0035418) | 4.36206831 |
| 16 | neurotransmitter secretion (GO:0007269) | 4.34302801 |
| 17 | regulation of synapse structural plasticity (GO:0051823) | 4.30621815 |
| 18 | layer formation in cerebral cortex (GO:0021819) | 4.27639047 |
| 19 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.23263762 |
| 20 | exploration behavior (GO:0035640) | 4.22046977 |
| 21 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.21442853 |
| 22 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.21093436 |
| 23 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.16071182 |
| 24 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.14497729 |
| 25 | regulation of early endosome to late endosome transport (GO:2000641) | 4.06172087 |
| 26 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.05098875 |
| 27 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.95344444 |
| 28 | ribosomal small subunit biogenesis (GO:0042274) | 3.83950683 |
| 29 | neuromuscular process controlling posture (GO:0050884) | 3.82460325 |
| 30 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.78893710 |
| 31 | proline transport (GO:0015824) | 3.74455155 |
| 32 | gamma-aminobutyric acid transport (GO:0015812) | 3.74074962 |
| 33 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.73898109 |
| 34 | dendritic spine morphogenesis (GO:0060997) | 3.71031258 |
| 35 | synaptic transmission, glutamatergic (GO:0035249) | 3.69028712 |
| 36 | cellular potassium ion homeostasis (GO:0030007) | 3.68875624 |
| 37 | long-term memory (GO:0007616) | 3.68795316 |
| 38 | sodium ion export (GO:0071436) | 3.59035877 |
| 39 | positive regulation of protein dephosphorylation (GO:0035307) | 3.56430179 |
| 40 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.54876396 |
| 41 | neurotransmitter transport (GO:0006836) | 3.54502272 |
| 42 | positive regulation of membrane potential (GO:0045838) | 3.53912264 |
| 43 | glycine transport (GO:0015816) | 3.53780980 |
| 44 | neuron-neuron synaptic transmission (GO:0007270) | 3.53686486 |
| 45 | activation of protein kinase A activity (GO:0034199) | 3.53286849 |
| 46 | glutamate receptor signaling pathway (GO:0007215) | 3.47770141 |
| 47 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.47037660 |
| 48 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.44513667 |
| 49 | tooth mineralization (GO:0034505) | 3.43144567 |
| 50 | regulation of vesicle fusion (GO:0031338) | 3.42723806 |
| 51 | neuromuscular process controlling balance (GO:0050885) | 3.39916617 |
| 52 | transmission of nerve impulse (GO:0019226) | 3.39695227 |
| 53 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 3.38319575 |
| 54 | regulation of postsynaptic membrane potential (GO:0060078) | 3.36447655 |
| 55 | regulation of neurotransmitter secretion (GO:0046928) | 3.34776011 |
| 56 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.34263569 |
| 57 | regulation of synaptic plasticity (GO:0048167) | 3.34127165 |
| 58 | NIK/NF-kappaB signaling (GO:0038061) | 3.31726762 |
| 59 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.31550244 |
| 60 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.28950625 |
| 61 | neuronal ion channel clustering (GO:0045161) | 3.26075866 |
| 62 | regulation of neurotransmitter levels (GO:0001505) | 3.25781163 |
| 63 | neuron recognition (GO:0008038) | 3.23617842 |
| 64 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.23420016 |
| 65 | protein localization to endosome (GO:0036010) | 3.21288966 |
| 66 | synaptic vesicle endocytosis (GO:0048488) | 3.21251626 |
| 67 | calcium ion-dependent exocytosis (GO:0017156) | 3.19411215 |
| 68 | protein maturation by protein folding (GO:0022417) | 3.18592840 |
| 69 | regulation of ARF protein signal transduction (GO:0032012) | 3.16543734 |
| 70 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.14544766 |
| 71 | cell migration in hindbrain (GO:0021535) | 3.14127902 |
| 72 | auditory behavior (GO:0031223) | 3.13992267 |
| 73 | creatine metabolic process (GO:0006600) | 3.13478515 |
| 74 | positive regulation of synapse maturation (GO:0090129) | 3.12967832 |
| 75 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.12181055 |
| 76 | regulation of neurotransmitter transport (GO:0051588) | 3.11217851 |
| 77 | membrane depolarization during action potential (GO:0086010) | 3.10945897 |
| 78 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.09812670 |
| 79 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.08311132 |
| 80 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.06924067 |
| 81 | focal adhesion assembly (GO:0048041) | 3.05608902 |
| 82 | cell-substrate adherens junction assembly (GO:0007045) | 3.05608902 |
| 83 | long-term synaptic potentiation (GO:0060291) | 3.05424438 |
| 84 | response to acidic pH (GO:0010447) | 3.04595574 |
| 85 | mating behavior (GO:0007617) | 3.04391927 |
| 86 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.04168350 |
| 87 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.03859883 |
| 88 | membrane depolarization (GO:0051899) | 3.03069794 |
| 89 | response to parathyroid hormone (GO:0071107) | 3.01914835 |
| 90 | membrane hyperpolarization (GO:0060081) | 3.01686412 |
| 91 | modulation by virus of host process (GO:0019054) | 3.00107929 |
| 92 | prepulse inhibition (GO:0060134) | 2.99838926 |
| 93 | cell-cell junction maintenance (GO:0045217) | 2.98781123 |
| 94 | cell communication by electrical coupling (GO:0010644) | 2.98647322 |
| 95 | adherens junction assembly (GO:0034333) | 2.98407680 |
| 96 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.98002489 |
| 97 | modulation by symbiont of host cellular process (GO:0044068) | 2.95124526 |
| 98 | intraspecies interaction between organisms (GO:0051703) | 2.94907864 |
| 99 | social behavior (GO:0035176) | 2.94907864 |
| 100 | regulation of oxidative phosphorylation (GO:0002082) | 2.93618501 |
| 101 | response to auditory stimulus (GO:0010996) | 2.93325458 |
| 102 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.90527105 |
| 103 | positive regulation of neurotransmitter transport (GO:0051590) | 2.89828346 |
| 104 | regulation of synaptic transmission (GO:0050804) | 2.89258377 |
| 105 | dendrite morphogenesis (GO:0048813) | 2.88862609 |
| 106 | activation of Rac GTPase activity (GO:0032863) | 2.88552989 |
| 107 | positive regulation of dendritic spine development (GO:0060999) | 2.87693003 |
| 108 | positive regulation of synaptic transmission (GO:0050806) | 2.86853227 |
| 109 | regulation of protein dephosphorylation (GO:0035304) | 2.85937538 |
| 110 | cerebellar granule cell differentiation (GO:0021707) | 2.85697718 |
| 111 | neuromuscular process (GO:0050905) | 2.85436767 |
| 112 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.83454101 |
| 113 | adult walking behavior (GO:0007628) | 2.82921972 |
| 114 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.82287966 |
| 115 | cerebellar Purkinje cell layer development (GO:0021680) | 2.82219744 |
| 116 | regulation of dendritic spine development (GO:0060998) | 2.82128278 |
| 117 | axonal fasciculation (GO:0007413) | 2.81793655 |
| 118 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.81652808 |
| 119 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.80618215 |
| 120 | learning (GO:0007612) | 2.80431394 |
| 121 | postsynaptic membrane organization (GO:0001941) | 2.80185372 |
| 122 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.79329005 |
| 123 | synaptic transmission (GO:0007268) | 2.78453364 |
| 124 | regulation of synapse maturation (GO:0090128) | 2.76404621 |
| 125 | vesicle transport along microtubule (GO:0047496) | 2.76383738 |
| 126 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 2.75179567 |
| 127 | apoptotic process involved in morphogenesis (GO:0060561) | 2.74719347 |
| 128 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.73391960 |
| 129 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.70990387 |
| 130 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.69957526 |
| 131 | signal complex assembly (GO:0007172) | 2.68165595 |
| 132 | protein targeting to plasma membrane (GO:0072661) | 2.67470222 |
| 133 | dopamine receptor signaling pathway (GO:0007212) | 2.64331393 |
| 134 | activation of MAPKKK activity (GO:0000185) | 2.64230723 |
| 135 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.64187006 |
| 136 | negative regulation of cell size (GO:0045792) | 2.64116607 |
| 137 | amyloid precursor protein catabolic process (GO:0042987) | 2.63968815 |
| 138 | positive regulation of protein sumoylation (GO:0033235) | 2.60616894 |
| 139 | adenosine receptor signaling pathway (GO:0001973) | 2.58229026 |
| 140 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.55854481 |
| 141 | regulation of chromatin binding (GO:0035561) | 2.55118842 |
| 142 | viral transcription (GO:0019083) | 2.53605638 |
| 143 | positive regulation of myotube differentiation (GO:0010831) | 2.53354094 |
| 144 | outflow tract septum morphogenesis (GO:0003148) | 2.52389574 |
| 145 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.50995890 |
| 146 | regulation of ARF GTPase activity (GO:0032312) | 2.46845922 |
| 147 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.46353125 |
| 148 | negative regulation of cell killing (GO:0031342) | 2.46353125 |
| 149 | regulation of extracellular matrix disassembly (GO:0010715) | 2.45635123 |
| 150 | mannose metabolic process (GO:0006013) | 2.44151736 |
| 151 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.43969458 |
| 152 | protein retention in ER lumen (GO:0006621) | 2.41133190 |
| 153 | regulation of actin cytoskeleton reorganization (GO:2000249) | 2.40799024 |
| 154 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.39518096 |
| 155 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.35596348 |
| 156 | response to peptidoglycan (GO:0032494) | 2.34978737 |
| 157 | positive regulation of fibroblast migration (GO:0010763) | 2.34941004 |
| 158 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.32288724 |
| 159 | positive regulation of actin cytoskeleton reorganization (GO:2000251) | 2.32010755 |
| 160 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.31981334 |
| 161 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.31291971 |
| 162 | modulation by symbiont of host immune response (GO:0052553) | 2.30570800 |
| 163 | positive regulation by symbiont of host defense response (GO:0052509) | 2.30570800 |
| 164 | modulation by symbiont of host defense response (GO:0052031) | 2.30570800 |
| 165 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.30570800 |
| 166 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.30570800 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.95631375 |
| 2 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.13655735 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.98231599 |
| 4 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.96323800 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.94731747 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.90072314 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.89235786 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.77414305 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.74752657 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.74752657 |
| 11 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.68433643 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.65165466 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.63330405 |
| 14 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.49573513 |
| 15 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.48151997 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.47023110 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.46605916 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.46133747 |
| 19 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.45398210 |
| 20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.45261563 |
| 21 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.45064707 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.40891248 |
| 23 | MYC_22102868_ChIP-Seq_BL_Human | 2.35048300 |
| 24 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.33351095 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.32947169 |
| 26 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.29978556 |
| 27 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.28199037 |
| 28 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.25800348 |
| 29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.25741590 |
| 30 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.20794917 |
| 31 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.18630749 |
| 32 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.15036883 |
| 33 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 2.08539695 |
| 34 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.03788525 |
| 35 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.01939694 |
| 36 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.00698583 |
| 37 | P68_20966046_ChIP-Seq_HELA_Human | 1.91120415 |
| 38 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.90543381 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.88853662 |
| 40 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.87067536 |
| 41 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.84718689 |
| 42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.83632582 |
| 43 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.74202891 |
| 44 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.71315953 |
| 45 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.70493785 |
| 46 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.66020674 |
| 47 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.65115119 |
| 48 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.59285949 |
| 49 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.58725631 |
| 50 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.57417636 |
| 51 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.55025182 |
| 52 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.52371168 |
| 53 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.50224144 |
| 54 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.49522457 |
| 55 | KDM2B_26808549_Chip-Seq_K562_Human | 1.48429394 |
| 56 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.48199162 |
| 57 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.47286352 |
| 58 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.47060741 |
| 59 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.46953139 |
| 60 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.46087953 |
| 61 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.45364836 |
| 62 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.43987492 |
| 63 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.43104129 |
| 64 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.42214513 |
| 65 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.41774196 |
| 66 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.41485006 |
| 67 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.38815163 |
| 68 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.38093601 |
| 69 | MAF_26560356_Chip-Seq_TH2_Human | 1.37965923 |
| 70 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.37852400 |
| 71 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.37381873 |
| 72 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.36849344 |
| 73 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.35723287 |
| 74 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.33863688 |
| 75 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.33309852 |
| 76 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.31149874 |
| 77 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.30313150 |
| 78 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.30180573 |
| 79 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.28870738 |
| 80 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.28826986 |
| 81 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.28555131 |
| 82 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.28292761 |
| 83 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.27277183 |
| 84 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.25666819 |
| 85 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.24275642 |
| 86 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.23288062 |
| 87 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.23261223 |
| 88 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.22221018 |
| 89 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.21489677 |
| 90 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.21213936 |
| 91 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.20494044 |
| 92 | MAF_26560356_Chip-Seq_TH1_Human | 1.20377620 |
| 93 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.20361440 |
| 94 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20245526 |
| 95 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.19834481 |
| 96 | SA1_27219007_Chip-Seq_Bcells_Human | 1.19275037 |
| 97 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.19174070 |
| 98 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.18822510 |
| 99 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.18803969 |
| 100 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.17752501 |
| 101 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.15385871 |
| 102 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.15254908 |
| 103 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.14164215 |
| 104 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.12385906 |
| 105 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.12196426 |
| 106 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.11715806 |
| 107 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10705142 |
| 108 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.10502849 |
| 109 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09708397 |
| 110 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09606225 |
| 111 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.09353714 |
| 112 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.09165285 |
| 113 | AR_19668381_ChIP-Seq_PC3_Human | 1.08875876 |
| 114 | UTX_26944678_Chip-Seq_JUKART_Human | 1.08574903 |
| 115 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.08461699 |
| 116 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.06859884 |
| 117 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.06504912 |
| 118 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.06499902 |
| 119 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.05350339 |
| 120 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.03170752 |
| 121 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.02496316 |
| 122 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.01790815 |
| 123 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.01621339 |
| 124 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.01512874 |
| 125 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.01314525 |
| 126 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.00635279 |
| 127 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99916551 |
| 128 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.99788371 |
| 129 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.99439416 |
| 130 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.99296287 |
| 131 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.99142743 |
| 132 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98403843 |
| 133 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.98349912 |
| 134 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.97600701 |
| 135 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.97545078 |
| 136 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.97224065 |
| 137 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96993011 |
| 138 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.96856731 |
| 139 | ATF3_27146783_Chip-Seq_COLON_Human | 0.96408953 |
| 140 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.95453759 |
| 141 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.93832256 |
| 142 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.93739711 |
| 143 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.93090645 |
| 144 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.91929319 |
| 145 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.90536811 |
| 146 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.89733983 |
| 147 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89608861 |
| 148 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.89595310 |
| 149 | AR_25329375_ChIP-Seq_VCAP_Human | 0.88443063 |
| 150 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.87464606 |
| 151 | STAT3_23295773_ChIP-Seq_U87_Human | 0.87151972 |
| 152 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.86676583 |
| 153 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86460011 |
| 154 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.86309563 |
| 155 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.85598562 |
| 156 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.85474119 |
| 157 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.85152632 |
| 158 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84327716 |
| 159 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.83577965 |
| 160 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.82929197 |
| 161 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.82693623 |
| 162 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.82085502 |
| 163 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.81549794 |
| 164 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.81516739 |
| 165 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.79956643 |
| 166 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.79244239 |
| 167 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78894423 |
| 168 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.78766942 |
| 169 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.78608586 |
| 170 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.76232217 |
| 171 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.74100807 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.29367293 |
| 2 | MP0003880_abnormal_central_pattern | 4.76517312 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.04001258 |
| 4 | MP0004270_analgesia | 3.59282403 |
| 5 | MP0005451_abnormal_body_composition | 3.50169898 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 3.25872272 |
| 7 | MP0009745_abnormal_behavioral_response | 3.25583141 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.13167456 |
| 9 | MP0002064_seizures | 3.09344481 |
| 10 | MP0002822_catalepsy | 3.07000199 |
| 11 | MP0004510_myositis | 3.02583775 |
| 12 | MP0009046_muscle_twitch | 2.95585426 |
| 13 | MP0003123_paternal_imprinting | 2.88255663 |
| 14 | MP0001968_abnormal_touch/_nociception | 2.84343137 |
| 15 | MP0009379_abnormal_foot_pigmentation | 2.72767711 |
| 16 | MP0002272_abnormal_nervous_system | 2.65185341 |
| 17 | MP0005058_abnormal_lysosome_morphology | 2.64155830 |
| 18 | MP0002572_abnormal_emotion/affect_behav | 2.63284677 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 2.62841939 |
| 20 | MP0000678_abnormal_parathyroid_gland | 2.55510760 |
| 21 | MP0005423_abnormal_somatic_nervous | 2.39243442 |
| 22 | MP0001486_abnormal_startle_reflex | 2.36966940 |
| 23 | MP0002733_abnormal_thermal_nociception | 2.30010876 |
| 24 | MP0003303_peritoneal_inflammation | 2.23605087 |
| 25 | MP0002909_abnormal_adrenal_gland | 2.22531690 |
| 26 | MP0001970_abnormal_pain_threshold | 2.22424012 |
| 27 | MP0003329_amyloid_beta_deposits | 2.19972324 |
| 28 | MP0001501_abnormal_sleep_pattern | 2.18173043 |
| 29 | MP0002736_abnormal_nociception_after | 2.16687425 |
| 30 | MP0008569_lethality_at_weaning | 2.11685835 |
| 31 | MP0002249_abnormal_larynx_morphology | 2.11500150 |
| 32 | MP0008260_abnormal_autophagy | 2.06641035 |
| 33 | MP0001440_abnormal_grooming_behavior | 2.00696931 |
| 34 | MP0009780_abnormal_chondrocyte_physiolo | 1.99312843 |
| 35 | MP0004858_abnormal_nervous_system | 1.98305504 |
| 36 | MP0002735_abnormal_chemical_nociception | 1.96689325 |
| 37 | MP0009840_abnormal_foam_cell | 1.86203604 |
| 38 | MP0002067_abnormal_sensory_capabilities | 1.79417337 |
| 39 | MP0004811_abnormal_neuron_physiology | 1.76582408 |
| 40 | MP0006276_abnormal_autonomic_nervous | 1.76339891 |
| 41 | MP0000013_abnormal_adipose_tissue | 1.70511792 |
| 42 | MP0005410_abnormal_fertilization | 1.70296935 |
| 43 | MP0000955_abnormal_spinal_cord | 1.65152975 |
| 44 | MP0005623_abnormal_meninges_morphology | 1.60607596 |
| 45 | MP0000759_abnormal_skeletal_muscle | 1.60246533 |
| 46 | MP0004185_abnormal_adipocyte_glucose | 1.59830773 |
| 47 | MP0002184_abnormal_innervation | 1.58759109 |
| 48 | MP0002877_abnormal_melanocyte_morpholog | 1.57838715 |
| 49 | MP0002557_abnormal_social/conspecific_i | 1.57262086 |
| 50 | MP0003122_maternal_imprinting | 1.56331215 |
| 51 | MP0005386_behavior/neurological_phenoty | 1.55637074 |
| 52 | MP0004924_abnormal_behavior | 1.55637074 |
| 53 | MP0003879_abnormal_hair_cell | 1.54200824 |
| 54 | MP0010030_abnormal_orbit_morphology | 1.53023258 |
| 55 | MP0003436_decreased_susceptibility_to | 1.50295035 |
| 56 | MP0000778_abnormal_nervous_system | 1.49868419 |
| 57 | MP0002089_abnormal_postnatal_growth/wei | 1.49066893 |
| 58 | MP0009333_abnormal_splenocyte_physiolog | 1.46932747 |
| 59 | MP0002066_abnormal_motor_capabilities/c | 1.43713360 |
| 60 | MP0000750_abnormal_muscle_regeneration | 1.43543152 |
| 61 | MP0001529_abnormal_vocalization | 1.39140906 |
| 62 | MP0004142_abnormal_muscle_tone | 1.38230217 |
| 63 | MP0004885_abnormal_endolymph | 1.38021231 |
| 64 | MP0002882_abnormal_neuron_morphology | 1.37271791 |
| 65 | MP0003787_abnormal_imprinting | 1.34335876 |
| 66 | MP0005646_abnormal_pituitary_gland | 1.33724475 |
| 67 | MP0003633_abnormal_nervous_system | 1.33352662 |
| 68 | MP0001984_abnormal_olfaction | 1.32109521 |
| 69 | MP0000733_abnormal_muscle_development | 1.26911005 |
| 70 | MP0005645_abnormal_hypothalamus_physiol | 1.26532561 |
| 71 | MP0002234_abnormal_pharynx_morphology | 1.24896989 |
| 72 | MP0001346_abnormal_lacrimal_gland | 1.23727778 |
| 73 | MP0001905_abnormal_dopamine_level | 1.23444746 |
| 74 | MP0000751_myopathy | 1.20643845 |
| 75 | MP0004130_abnormal_muscle_cell | 1.18996782 |
| 76 | MP0000920_abnormal_myelination | 1.18423824 |
| 77 | MP0004145_abnormal_muscle_electrophysio | 1.16764830 |
| 78 | MP0003453_abnormal_keratinocyte_physiol | 1.16388881 |
| 79 | MP0010386_abnormal_urinary_bladder | 1.16365856 |
| 80 | MP0003283_abnormal_digestive_organ | 1.15553381 |
| 81 | MP0005375_adipose_tissue_phenotype | 1.14358881 |
| 82 | MP0008961_abnormal_basal_metabolism | 1.13044953 |
| 83 | MP0005076_abnormal_cell_differentiation | 1.09821537 |
| 84 | MP0003631_nervous_system_phenotype | 1.08224800 |
| 85 | MP0005666_abnormal_adipose_tissue | 1.08128911 |
| 86 | MP0002152_abnormal_brain_morphology | 1.07117272 |
| 87 | MP0000681_abnormal_thyroid_gland | 1.07047193 |
| 88 | MP0005166_decreased_susceptibility_to | 1.05384753 |
| 89 | MP0009278_abnormal_bone_marrow | 1.05206389 |
| 90 | MP0004087_abnormal_muscle_fiber | 1.05071851 |
| 91 | MP0001849_ear_inflammation | 1.05037325 |
| 92 | MP0003634_abnormal_glial_cell | 1.04040329 |
| 93 | MP0002837_dystrophic_cardiac_calcinosis | 1.03426198 |
| 94 | MP0001502_abnormal_circadian_rhythm | 1.03367715 |
| 95 | MP0006036_abnormal_mitochondrial_physio | 1.02897738 |
| 96 | MP0003191_abnormal_cellular_cholesterol | 0.99593847 |
| 97 | MP0003279_aneurysm | 0.99482023 |
| 98 | MP0002229_neurodegeneration | 0.97408250 |
| 99 | MP0002269_muscular_atrophy | 0.94428861 |
| 100 | MP0003690_abnormal_glial_cell | 0.92585699 |
| 101 | MP0005409_darkened_coat_color | 0.92477572 |
| 102 | MP0002796_impaired_skin_barrier | 0.92431922 |
| 103 | MP0000604_amyloidosis | 0.92244946 |
| 104 | MP0008874_decreased_physiological_sensi | 0.91701294 |
| 105 | MP0002069_abnormal_eating/drinking_beha | 0.89913981 |
| 106 | MP0002332_abnormal_exercise_endurance | 0.87883846 |
| 107 | MP0008872_abnormal_physiological_respon | 0.87196917 |
| 108 | MP0004043_abnormal_pH_regulation | 0.85969912 |
| 109 | MP0002653_abnormal_ependyma_morphology | 0.84652795 |
| 110 | MP0002106_abnormal_muscle_physiology | 0.83657782 |
| 111 | MP0004742_abnormal_vestibular_system | 0.83320830 |
| 112 | MP0000749_muscle_degeneration | 0.83027732 |
| 113 | MP0005330_cardiomyopathy | 0.82393579 |
| 114 | MP0004085_abnormal_heartbeat | 0.82297999 |
| 115 | MP0000003_abnormal_adipose_tissue | 0.80977470 |
| 116 | MP0005535_abnormal_body_temperature | 0.78929665 |
| 117 | MP0000858_altered_metastatic_potential | 0.78663418 |
| 118 | MP0004233_abnormal_muscle_weight | 0.78578177 |
| 119 | MP0003075_altered_response_to | 0.78271610 |
| 120 | MP0001348_abnormal_lacrimal_gland | 0.76643099 |
| 121 | MP0001853_heart_inflammation | 0.73890706 |
| 122 | MP0003632_abnormal_nervous_system | 0.72750728 |
| 123 | MP0000747_muscle_weakness | 0.70665025 |
| 124 | MP0005394_taste/olfaction_phenotype | 0.69912320 |
| 125 | MP0005499_abnormal_olfactory_system | 0.69912320 |
| 126 | MP0000631_abnormal_neuroendocrine_gland | 0.68870337 |
| 127 | MP0004947_skin_inflammation | 0.67422318 |
| 128 | MP0010234_abnormal_vibrissa_follicle | 0.66886561 |
| 129 | MP0003172_abnormal_lysosome_physiology | 0.66707467 |
| 130 | MP0002752_abnormal_somatic_nervous | 0.66624768 |
| 131 | MP0001963_abnormal_hearing_physiology | 0.66602441 |
| 132 | MP0001188_hyperpigmentation | 0.66549304 |
| 133 | MP0005025_abnormal_response_to | 0.65960171 |
| 134 | MP0009672_abnormal_birth_weight | 0.65766340 |
| 135 | MP0005501_abnormal_skin_physiology | 0.65389193 |
| 136 | MP0001299_abnormal_eye_distance/ | 0.65006530 |
| 137 | MP0003137_abnormal_impulse_conducting | 0.64972402 |
| 138 | MP0005000_abnormal_immune_tolerance | 0.63902431 |
| 139 | MP0001533_abnormal_skeleton_physiology | 0.63064830 |
| 140 | MP0003698_abnormal_male_reproductive | 0.62662626 |
| 141 | MP0005670_abnormal_white_adipose | 0.62356536 |
| 142 | MP0002932_abnormal_joint_morphology | 0.61953975 |
| 143 | MP0005369_muscle_phenotype | 0.60763390 |
| 144 | MP0001177_atelectasis | 0.60503590 |
| 145 | MP0001943_abnormal_respiration | 0.59466361 |
| 146 | MP0002163_abnormal_gland_morphology | 0.58017396 |
| 147 | MP0003183_abnormal_peptide_metabolism | 0.57925076 |
| 148 | MP0005551_abnormal_eye_electrophysiolog | 0.57281882 |
| 149 | MP0002090_abnormal_vision | 0.57216747 |
| 150 | MP0001485_abnormal_pinna_reflex | 0.56610136 |
| 151 | MP0004381_abnormal_hair_follicle | 0.56414556 |
| 152 | MP0010630_abnormal_cardiac_muscle | 0.56335188 |
| 153 | MP0002998_abnormal_bone_remodeling | 0.56331652 |
| 154 | MP0003861_abnormal_nervous_system | 0.54614926 |
| 155 | MP0010769_abnormal_survival | 0.54055351 |
| 156 | MP0008877_abnormal_DNA_methylation | 0.53225950 |
| 157 | MP0002638_abnormal_pupillary_reflex | 0.52718854 |
| 158 | MP0003956_abnormal_body_size | 0.52437073 |
| 159 | MP0000569_abnormal_digit_pigmentation | 0.52425183 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 7.06966428 |
| 2 | Focal motor seizures (HP:0011153) | 6.65371207 |
| 3 | Focal seizures (HP:0007359) | 5.30564574 |
| 4 | Visual hallucinations (HP:0002367) | 5.14736095 |
| 5 | Atonic seizures (HP:0010819) | 4.75340092 |
| 6 | Supranuclear gaze palsy (HP:0000605) | 4.44412676 |
| 7 | Epileptic encephalopathy (HP:0200134) | 4.10250404 |
| 8 | Absence seizures (HP:0002121) | 3.98312342 |
| 9 | Action tremor (HP:0002345) | 3.82702244 |
| 10 | Progressive cerebellar ataxia (HP:0002073) | 3.69943280 |
| 11 | Ankle clonus (HP:0011448) | 3.60721318 |
| 12 | Obstructive sleep apnea (HP:0002870) | 3.56956847 |
| 13 | Dialeptic seizures (HP:0011146) | 3.46649840 |
| 14 | Febrile seizures (HP:0002373) | 3.43915742 |
| 15 | Double outlet right ventricle (HP:0001719) | 3.43113776 |
| 16 | Congenital malformation of the right heart (HP:0011723) | 3.43113776 |
| 17 | Generalized tonic-clonic seizures (HP:0002069) | 3.35761448 |
| 18 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.16725397 |
| 19 | Depression (HP:0000716) | 3.14855359 |
| 20 | Amblyopia (HP:0000646) | 3.14218344 |
| 21 | Hyperthyroidism (HP:0000836) | 3.06518000 |
| 22 | Neurofibrillary tangles (HP:0002185) | 3.01372483 |
| 23 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.98071776 |
| 24 | Dysmetria (HP:0001310) | 2.97657517 |
| 25 | Achilles tendon contracture (HP:0001771) | 2.97071156 |
| 26 | Cerebral inclusion bodies (HP:0100314) | 2.91076193 |
| 27 | Papilledema (HP:0001085) | 2.88084839 |
| 28 | Anxiety (HP:0000739) | 2.88046153 |
| 29 | Poor eye contact (HP:0000817) | 2.87019434 |
| 30 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.86012341 |
| 31 | Abnormal eating behavior (HP:0100738) | 2.84551269 |
| 32 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.82776491 |
| 33 | Spastic gait (HP:0002064) | 2.82710172 |
| 34 | Myopathic facies (HP:0002058) | 2.78190976 |
| 35 | Abnormality of the lower motor neuron (HP:0002366) | 2.75645859 |
| 36 | Truncus arteriosus (HP:0001660) | 2.75414307 |
| 37 | Dysdiadochokinesis (HP:0002075) | 2.74843239 |
| 38 | Postural instability (HP:0002172) | 2.72637422 |
| 39 | Megalencephaly (HP:0001355) | 2.72216918 |
| 40 | Impaired social interactions (HP:0000735) | 2.69019909 |
| 41 | Abnormal social behavior (HP:0012433) | 2.69019909 |
| 42 | Abnormality of the Achilles tendon (HP:0005109) | 2.66040159 |
| 43 | Broad-based gait (HP:0002136) | 2.65967721 |
| 44 | Hyperacusis (HP:0010780) | 2.64624863 |
| 45 | Truncal ataxia (HP:0002078) | 2.64466555 |
| 46 | Urinary urgency (HP:0000012) | 2.62449378 |
| 47 | Gaze-evoked nystagmus (HP:0000640) | 2.61670829 |
| 48 | Hemiparesis (HP:0001269) | 2.56803076 |
| 49 | Torticollis (HP:0000473) | 2.55197984 |
| 50 | Impaired smooth pursuit (HP:0007772) | 2.52949260 |
| 51 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.52857646 |
| 52 | Hyperparathyroidism (HP:0000843) | 2.52794342 |
| 53 | Insidious onset (HP:0003587) | 2.52641969 |
| 54 | Termporal pattern (HP:0011008) | 2.52641969 |
| 55 | Increased variability in muscle fiber diameter (HP:0003557) | 2.51246349 |
| 56 | Exercise-induced myalgia (HP:0003738) | 2.49019754 |
| 57 | Pheochromocytoma (HP:0002666) | 2.49009252 |
| 58 | Hypokinesia (HP:0002375) | 2.48332413 |
| 59 | Type 1 muscle fiber predominance (HP:0003803) | 2.48158460 |
| 60 | Vertebral compression fractures (HP:0002953) | 2.47035156 |
| 61 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.45588601 |
| 62 | Mutism (HP:0002300) | 2.44307640 |
| 63 | Stridor (HP:0010307) | 2.43097303 |
| 64 | Distal lower limb muscle weakness (HP:0009053) | 2.41262115 |
| 65 | Ventricular fibrillation (HP:0001663) | 2.40244841 |
| 66 | Bundle branch block (HP:0011710) | 2.38485188 |
| 67 | Annular pancreas (HP:0001734) | 2.37145769 |
| 68 | Genetic anticipation (HP:0003743) | 2.36888972 |
| 69 | Abnormality of the corticospinal tract (HP:0002492) | 2.36828376 |
| 70 | Agitation (HP:0000713) | 2.36728433 |
| 71 | Rapidly progressive (HP:0003678) | 2.36084208 |
| 72 | Hemiplegia (HP:0002301) | 2.36062744 |
| 73 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.33452971 |
| 74 | Focal dystonia (HP:0004373) | 2.31427104 |
| 75 | Muscle fiber inclusion bodies (HP:0100299) | 2.30254476 |
| 76 | Bulbar palsy (HP:0001283) | 2.29286006 |
| 77 | Hypercortisolism (HP:0001578) | 2.28069349 |
| 78 | Neuronal loss in central nervous system (HP:0002529) | 2.27748600 |
| 79 | Bradykinesia (HP:0002067) | 2.27584357 |
| 80 | Failure to thrive in infancy (HP:0001531) | 2.25078380 |
| 81 | Insomnia (HP:0100785) | 2.24708858 |
| 82 | Long palpebral fissure (HP:0000637) | 2.24692453 |
| 83 | Intention tremor (HP:0002080) | 2.22408858 |
| 84 | Round ear (HP:0100830) | 2.21921498 |
| 85 | Neuroendocrine neoplasm (HP:0100634) | 2.20867543 |
| 86 | Ragged-red muscle fibers (HP:0003200) | 2.20177031 |
| 87 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.19646592 |
| 88 | Ankyloglossia (HP:0010296) | 2.19638352 |
| 89 | Axonal loss (HP:0003447) | 2.19526909 |
| 90 | Lower limb muscle weakness (HP:0007340) | 2.19519023 |
| 91 | Stereotypic behavior (HP:0000733) | 2.18803434 |
| 92 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.16450788 |
| 93 | Nemaline bodies (HP:0003798) | 2.16352062 |
| 94 | Craniofacial dystonia (HP:0012179) | 2.16057940 |
| 95 | Distal lower limb amyotrophy (HP:0008944) | 2.15670885 |
| 96 | Recurrent bacterial skin infections (HP:0005406) | 2.14844019 |
| 97 | Increased connective tissue (HP:0009025) | 2.13170555 |
| 98 | Deep palmar crease (HP:0006191) | 2.12856154 |
| 99 | EEG with generalized epileptiform discharges (HP:0011198) | 2.10719726 |
| 100 | Epileptiform EEG discharges (HP:0011182) | 2.09642873 |
| 101 | Testicular atrophy (HP:0000029) | 2.09414167 |
| 102 | Delusions (HP:0000746) | 2.08901547 |
| 103 | Dysmetric saccades (HP:0000641) | 2.08787145 |
| 104 | Recurrent abscess formation (HP:0002722) | 2.08725355 |
| 105 | Slow saccadic eye movements (HP:0000514) | 2.08552598 |
| 106 | Hyperventilation (HP:0002883) | 2.08542317 |
| 107 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.08030366 |
| 108 | Hypoventilation (HP:0002791) | 2.07294311 |
| 109 | Absent/shortened dynein arms (HP:0200106) | 2.05593507 |
| 110 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.05593507 |
| 111 | Progressive inability to walk (HP:0002505) | 2.05297529 |
| 112 | Impaired vibratory sensation (HP:0002495) | 2.05116837 |
| 113 | Hypsarrhythmia (HP:0002521) | 2.04551050 |
| 114 | Diplopia (HP:0000651) | 2.02237919 |
| 115 | Abnormality of binocular vision (HP:0011514) | 2.02237919 |
| 116 | Clonus (HP:0002169) | 2.02202310 |
| 117 | Abnormality of saccadic eye movements (HP:0000570) | 2.02089376 |
| 118 | Ulnar deviation of the wrist (HP:0003049) | 2.01100429 |
| 119 | Scanning speech (HP:0002168) | 2.00978269 |
| 120 | Pointed chin (HP:0000307) | 2.00875231 |
| 121 | Abnormal EKG (HP:0003115) | 2.00263752 |
| 122 | Progressive muscle weakness (HP:0003323) | 2.00135577 |
| 123 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.99946330 |
| 124 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.99946330 |
| 125 | Status epilepticus (HP:0002133) | 1.99490063 |
| 126 | Muscle stiffness (HP:0003552) | 1.98791940 |
| 127 | Slender build (HP:0001533) | 1.97800708 |
| 128 | Abnormality of oral frenula (HP:0000190) | 1.92992447 |
| 129 | Polygenic inheritance (HP:0010982) | 1.92962106 |
| 130 | Polyphagia (HP:0002591) | 1.92450920 |
| 131 | Bowel incontinence (HP:0002607) | 1.92058754 |
| 132 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.91815336 |
| 133 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.91815336 |
| 134 | Abnormality of glycolipid metabolism (HP:0010969) | 1.91815336 |
| 135 | Hypertensive crisis (HP:0100735) | 1.91423338 |
| 136 | Psychosis (HP:0000709) | 1.91138252 |
| 137 | Abnormality of the tricuspid valve (HP:0001702) | 1.90865315 |
| 138 | Drooling (HP:0002307) | 1.90729668 |
| 139 | Excessive salivation (HP:0003781) | 1.90729668 |
| 140 | Resting tremor (HP:0002322) | 1.90648747 |
| 141 | Apathy (HP:0000741) | 1.90209375 |
| 142 | Limb dystonia (HP:0002451) | 1.90197703 |
| 143 | Distal upper limb amyotrophy (HP:0007149) | 1.89964003 |
| 144 | Upper limb amyotrophy (HP:0009129) | 1.89964003 |
| 145 | Generalized hypotonia (HP:0001290) | 1.88992358 |
| 146 | Diminished motivation (HP:0000745) | 1.87944158 |
| 147 | Asymmetric septal hypertrophy (HP:0001670) | 1.87469262 |
| 148 | Abnormality of the aortic arch (HP:0012303) | 1.87261546 |
| 149 | Dementia (HP:0000726) | 1.86794912 |
| 150 | Abnormal large intestine physiology (HP:0012700) | 1.85263268 |
| 151 | Progressive neurologic deterioration (HP:0002344) | 1.84180511 |
| 152 | EMG: myopathic abnormalities (HP:0003458) | 1.83719688 |
| 153 | Rigidity (HP:0002063) | 1.83389460 |
| 154 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.82572933 |
| 155 | Genu recurvatum (HP:0002816) | 1.82469239 |
| 156 | Generalized myoclonic seizures (HP:0002123) | 1.82187504 |
| 157 | Spinal canal stenosis (HP:0003416) | 1.80678524 |
| 158 | Peripheral hypomyelination (HP:0007182) | 1.80340357 |
| 159 | Abnormality of macrophages (HP:0004311) | 1.78729616 |
| 160 | Athetosis (HP:0002305) | 1.78623707 |
| 161 | Tetraplegia (HP:0002445) | 1.77654867 |
| 162 | Myotonia (HP:0002486) | 1.77521127 |
| 163 | Abnormal ventriculo-arterial connection (HP:0011563) | 1.77431345 |
| 164 | Transposition of the great arteries (HP:0001669) | 1.77431345 |
| 165 | Abnormal connection of the cardiac segments (HP:0011545) | 1.77431345 |
| 166 | Gait ataxia (HP:0002066) | 1.77004862 |
| 167 | Lower limb amyotrophy (HP:0007210) | 1.76937163 |
| 168 | Dysostosis multiplex (HP:0000943) | 1.74370172 |
| 169 | Broad distal phalanx of finger (HP:0009836) | 1.74033939 |
| 170 | Nuclear cataract (HP:0100018) | 1.72848436 |
| 171 | Hypoplastic left heart (HP:0004383) | 1.72423514 |
| 172 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.72148412 |
| 173 | Turricephaly (HP:0000262) | 1.71955647 |
| 174 | Cerebral aneurysm (HP:0004944) | 1.69356389 |
| 175 | Generalized amyotrophy (HP:0003700) | 1.68858886 |
| 176 | Increased serum ferritin (HP:0003281) | 1.67255933 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.91416357 |
| 2 | MAP3K9 | 3.73641572 |
| 3 | SMG1 | 3.32497184 |
| 4 | PRKD3 | 3.26566629 |
| 5 | EPHA4 | 3.22849149 |
| 6 | MAP3K4 | 2.94879932 |
| 7 | IRAK3 | 2.94185431 |
| 8 | PAK6 | 2.72684681 |
| 9 | KSR2 | 2.63130193 |
| 10 | MINK1 | 2.55164728 |
| 11 | SIK1 | 2.47246202 |
| 12 | ERN1 | 2.40848765 |
| 13 | MAP3K11 | 2.33120388 |
| 14 | NME2 | 2.30790207 |
| 15 | CAMKK1 | 2.13449235 |
| 16 | NTRK1 | 2.12173856 |
| 17 | NTRK2 | 2.00463413 |
| 18 | MAP2K7 | 1.92739357 |
| 19 | MARK1 | 1.92244477 |
| 20 | DAPK2 | 1.91386006 |
| 21 | ARAF | 1.84434982 |
| 22 | MAP3K12 | 1.84107637 |
| 23 | TAOK2 | 1.82051101 |
| 24 | MAP2K4 | 1.79709907 |
| 25 | GRK5 | 1.73371129 |
| 26 | RIPK4 | 1.71994051 |
| 27 | MAP3K2 | 1.66090164 |
| 28 | BRAF | 1.63158651 |
| 29 | TYRO3 | 1.62970759 |
| 30 | IRAK2 | 1.62877702 |
| 31 | PNCK | 1.61148237 |
| 32 | EEF2K | 1.57106204 |
| 33 | TAOK1 | 1.54671401 |
| 34 | LATS2 | 1.51347971 |
| 35 | UHMK1 | 1.49360938 |
| 36 | CDK19 | 1.49337938 |
| 37 | MAP2K3 | 1.46811298 |
| 38 | STK16 | 1.46517091 |
| 39 | CAMKK2 | 1.44898738 |
| 40 | CDK5 | 1.44789187 |
| 41 | STK38 | 1.42027792 |
| 42 | KSR1 | 1.32736159 |
| 43 | VRK2 | 1.31423834 |
| 44 | SIK2 | 1.31410387 |
| 45 | PRKCH | 1.24448474 |
| 46 | IRAK4 | 1.23919652 |
| 47 | TAF1 | 1.23412996 |
| 48 | TTN | 1.22633972 |
| 49 | FES | 1.17545813 |
| 50 | ICK | 1.14332331 |
| 51 | DAPK1 | 1.13750791 |
| 52 | MAP3K13 | 1.09548284 |
| 53 | PRKCG | 1.08263724 |
| 54 | RET | 1.06593027 |
| 55 | MAPK12 | 1.05647756 |
| 56 | MAP4K1 | 1.05625760 |
| 57 | TRIB3 | 1.04709865 |
| 58 | MAP3K1 | 1.03661077 |
| 59 | STK11 | 1.00811096 |
| 60 | CDK12 | 1.00398068 |
| 61 | PRKG2 | 0.94483622 |
| 62 | WNK1 | 0.94354643 |
| 63 | LMTK2 | 0.93758695 |
| 64 | CDK15 | 0.92372775 |
| 65 | CDK18 | 0.91542700 |
| 66 | MARK2 | 0.91476609 |
| 67 | CDK14 | 0.89628728 |
| 68 | PDPK1 | 0.88802402 |
| 69 | PDK1 | 0.88387720 |
| 70 | PHKG1 | 0.88136907 |
| 71 | PHKG2 | 0.88136907 |
| 72 | RAF1 | 0.86800126 |
| 73 | PLK2 | 0.84462411 |
| 74 | ALK | 0.84147170 |
| 75 | TESK2 | 0.82506066 |
| 76 | CDK11A | 0.82355498 |
| 77 | OXSR1 | 0.82119234 |
| 78 | PAK3 | 0.82020562 |
| 79 | MAPK13 | 0.81042912 |
| 80 | PTK2B | 0.80960715 |
| 81 | CAMK2A | 0.80423041 |
| 82 | PINK1 | 0.79615414 |
| 83 | DMPK | 0.79285076 |
| 84 | RIPK1 | 0.78359012 |
| 85 | CAMK1 | 0.78271753 |
| 86 | WNK4 | 0.77837309 |
| 87 | STK39 | 0.77708125 |
| 88 | PRPF4B | 0.76340103 |
| 89 | MAPK11 | 0.75268806 |
| 90 | TNIK | 0.74560938 |
| 91 | GRK6 | 0.74358226 |
| 92 | TNK2 | 0.74253001 |
| 93 | CAMK1G | 0.72966459 |
| 94 | RPS6KA2 | 0.72577463 |
| 95 | LRRK2 | 0.71859359 |
| 96 | MAP3K3 | 0.68476738 |
| 97 | CAMK2B | 0.66225824 |
| 98 | PDK3 | 0.64628514 |
| 99 | PDK4 | 0.64628514 |
| 100 | MAP3K10 | 0.63443511 |
| 101 | SGK223 | 0.61475586 |
| 102 | SGK494 | 0.61475586 |
| 103 | ABL2 | 0.61355800 |
| 104 | MTOR | 0.60881532 |
| 105 | RPS6KL1 | 0.58003226 |
| 106 | RPS6KC1 | 0.58003226 |
| 107 | SIK3 | 0.57839704 |
| 108 | MAP3K8 | 0.57241504 |
| 109 | MAP2K2 | 0.56453815 |
| 110 | PDGFRA | 0.55948104 |
| 111 | AKT2 | 0.55931865 |
| 112 | HIPK2 | 0.55705161 |
| 113 | ROCK2 | 0.54765165 |
| 114 | PTK6 | 0.54251039 |
| 115 | TYK2 | 0.49599333 |
| 116 | ZAP70 | 0.48951248 |
| 117 | MOS | 0.48922088 |
| 118 | DDR2 | 0.48304575 |
| 119 | PKN2 | 0.47501798 |
| 120 | DAPK3 | 0.47480013 |
| 121 | CAMK2D | 0.46326780 |
| 122 | MAPK10 | 0.45785562 |
| 123 | CAMK2G | 0.44831782 |
| 124 | CDC42BPA | 0.44537107 |
| 125 | TESK1 | 0.44506460 |
| 126 | PTK2 | 0.43399069 |
| 127 | SGK1 | 0.42940908 |
| 128 | LIMK1 | 0.42724209 |
| 129 | RPS6KA3 | 0.41702579 |
| 130 | MAPK4 | 0.41122863 |
| 131 | PRKCZ | 0.41093144 |
| 132 | NME1 | 0.41071052 |
| 133 | DYRK1B | 0.40903755 |
| 134 | PRKD2 | 0.40048141 |
| 135 | AURKA | 0.39610773 |
| 136 | MAP2K1 | 0.39374088 |
| 137 | SCYL2 | 0.38352031 |
| 138 | CSNK1G2 | 0.38020558 |
| 139 | PIM2 | 0.37197822 |
| 140 | BMPR2 | 0.37187799 |
| 141 | FYN | 0.36543667 |
| 142 | RPS6KA6 | 0.36442336 |
| 143 | NEK6 | 0.36254581 |
| 144 | BRSK1 | 0.36003262 |
| 145 | ILK | 0.35252876 |
| 146 | DYRK1A | 0.34401583 |
| 147 | PRKCI | 0.34375969 |
| 148 | MAP3K6 | 0.34194919 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.27844071 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.03541107 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.56259012 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.51008318 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.47634374 |
| 6 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.45877227 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.35408072 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.34091038 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.33961805 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.27853085 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 2.19534967 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.11717097 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 2.06084382 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.99071636 |
| 15 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.98934171 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.93782030 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.89407472 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.87586074 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.74658116 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.73499014 |
| 21 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.71625222 |
| 22 | Cocaine addiction_Homo sapiens_hsa05030 | 1.68101439 |
| 23 | Sulfur relay system_Homo sapiens_hsa04122 | 1.65189063 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.61283420 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.60808217 |
| 26 | Taste transduction_Homo sapiens_hsa04742 | 1.58624098 |
| 27 | Long-term depression_Homo sapiens_hsa04730 | 1.57758378 |
| 28 | Ribosome_Homo sapiens_hsa03010 | 1.53208041 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.48911507 |
| 30 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.48615727 |
| 31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.45772524 |
| 32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.44295766 |
| 33 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.41141625 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.38149882 |
| 35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.37785001 |
| 36 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.36548474 |
| 37 | Bladder cancer_Homo sapiens_hsa05219 | 1.35209495 |
| 38 | Gap junction_Homo sapiens_hsa04540 | 1.32956841 |
| 39 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.32526460 |
| 40 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.28259067 |
| 41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.26094846 |
| 42 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.26092066 |
| 43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.23629363 |
| 44 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.21601453 |
| 45 | Glioma_Homo sapiens_hsa05214 | 1.21281701 |
| 46 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.20473944 |
| 47 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.19243289 |
| 48 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.16158955 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.16023719 |
| 50 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.15612804 |
| 51 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.13203158 |
| 52 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.11383146 |
| 53 | Melanogenesis_Homo sapiens_hsa04916 | 1.06769255 |
| 54 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.06633073 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.05506770 |
| 56 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.04976319 |
| 57 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.03180423 |
| 58 | Axon guidance_Homo sapiens_hsa04360 | 1.01399439 |
| 59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.00705999 |
| 60 | Galactose metabolism_Homo sapiens_hsa00052 | 0.95572110 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.94142827 |
| 62 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.94087313 |
| 63 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93839805 |
| 64 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.92099126 |
| 65 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.91920736 |
| 66 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91762499 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.89044756 |
| 68 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.88922392 |
| 69 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.84607816 |
| 70 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.84499113 |
| 71 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.84461609 |
| 72 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.82550430 |
| 73 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.80687928 |
| 74 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.78622480 |
| 75 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.78341938 |
| 76 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.76802613 |
| 77 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.74773725 |
| 78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74305441 |
| 79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74292983 |
| 80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73891641 |
| 81 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.73230985 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.72974720 |
| 83 | Endocytosis_Homo sapiens_hsa04144 | 0.72285255 |
| 84 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.72018985 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71769809 |
| 86 | Tuberculosis_Homo sapiens_hsa05152 | 0.70861276 |
| 87 | Alzheimers disease_Homo sapiens_hsa05010 | 0.70654338 |
| 88 | Lysosome_Homo sapiens_hsa04142 | 0.69505961 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68997038 |
| 90 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68826795 |
| 91 | Thyroid cancer_Homo sapiens_hsa05216 | 0.67269274 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.66781142 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66669112 |
| 94 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.66280133 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65664398 |
| 96 | Salmonella infection_Homo sapiens_hsa05132 | 0.64460316 |
| 97 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.62767029 |
| 98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61623435 |
| 99 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61299826 |
| 100 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.60813923 |
| 101 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59136878 |
| 102 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.58990030 |
| 103 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58912434 |
| 104 | Hepatitis B_Homo sapiens_hsa05161 | 0.57442413 |
| 105 | Hepatitis C_Homo sapiens_hsa05160 | 0.55026635 |
| 106 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54791793 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54536265 |
| 108 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.54341749 |
| 109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.54119599 |
| 110 | Alcoholism_Homo sapiens_hsa05034 | 0.51674924 |
| 111 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51462883 |
| 112 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.51045064 |
| 113 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.50938041 |
| 114 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.49505344 |
| 115 | Parkinsons disease_Homo sapiens_hsa05012 | 0.49370283 |
| 116 | Prion diseases_Homo sapiens_hsa05020 | 0.48637294 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48311981 |
| 118 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.46536923 |
| 119 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.45754986 |
| 120 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.44756675 |
| 121 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.44570305 |
| 122 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43383241 |
| 123 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41977038 |
| 124 | Phototransduction_Homo sapiens_hsa04744 | 0.41686819 |
| 125 | Bile secretion_Homo sapiens_hsa04976 | 0.39610430 |
| 126 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.39243315 |
| 127 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.38927537 |
| 128 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.35739398 |
| 129 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.34926883 |
| 130 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.34581311 |
| 131 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.34556009 |
| 132 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.31859818 |
| 133 | Huntingtons disease_Homo sapiens_hsa05016 | 0.31754034 |
| 134 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.31343350 |

